XML 43 R33.htm IDEA: XBRL DOCUMENT
v3.22.2

Stock-Based Compensation (Details Narrative) - USD ($) |  |  |  |  |  |  |  |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 30, 2022 | Jun. 17, 2022 | Jun. 30, 2021 | May 11, 2021 | Apr. 09, 2021 | Jan. 06, 2021 | Aug. 12, 2020 | Aug. 01, 2020 | Jul. 15, 2020 | Jul. 14, 2020 | Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2022 | Jun. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option vested exercisable term |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 15 months |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | $ 424,094 | $ 850,804 | $ 763,766 | $ 1,506,836
Number of fully vested option exercisable | 2,225,000 |  |  |  |  |  |  |  |  |  | 2,225,000 |  | 2,225,000 |  | 2,225,000 |
Total deferred compensation expense for outstanding value of unvested stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,808,000 |
Fair market value, per share |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.74 |
Outstanding stock options to acquire shares of common stock not vested | 1,100,000 |  |  |  |  |  |  |  |  |  | 1,100,000 |  | 1,100,000 |  | 1,100,000 |
Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option vested exercisable term |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  | $ 3.21 |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  | $ 571,312 |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  | $ 2.8566 |  |  |  |  |  |  |  |  |  |
Number of fully vested option issued |  |  |  |  |  | 200,000 |  |  |  |  |  |  |  |  |  |
Non Officer Directors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options description | the Board of Directors, in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, granted to each of the five non-officer directors of the Company stock options exercisable for a period of five years to purchase 100,000 shares (a total of 500,000 shares) of the Company’s common stock at an exercise price of $0.74 per share (the closing market price on the grant date), vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested. The total fair value of the 500,000 stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $316,700 ($0.6334 per share), which is being charged to operations ratably from July 1, 2022 through June 30, 2023. During the three months and six months ended June 30, 2022, the Company did not record a charge to operations with respect to these stock options |  | the Board of Directors, in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, granted to each of the five non-officer directors of the Company stock options exercisable for a period of five years to purchase 100,000 shares (a total of 500,000 shares) of the Company’s common stock at an exercise price of $3.03 per share (the closing market price on the grant date), vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested. The total fair value of the 500,000 stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $1,421,095 ($2.84225 per share), which is being charged to operations ratably from July 1, 2021 through June 30, 2023. During the three months and six months ended June 30, 2022, the Company recorded a charge to general and administrative costs in the consolidated statement of operations of $177,150 and $352,355, respectively, with respect to these stock options |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option vested exercisable term |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share | $ 0.74 |  | $ 3.03 |  |  |  |  |  |  |  | $ 0.74 | $ 3.03 | $ 0.74 | $ 3.03 | $ 0.74 | $ 3.03
Fair value of stock options |  |  |  |  |  |  |  |  |  |  | $ 316,700 | $ 1,421,095 |  |  |  |
Stock price per share | $ 0.6334 |  | $ 2.84225 |  |  |  |  |  |  |  | $ 0.6334 | $ 2.84225 | $ 0.6334 | $ 2.84225 | $ 0.6334 | $ 2.84225
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | $ 177,150 |  | $ 352,355 |
Number of fully vested option exercisable | 500,000 |  | 500,000 |  |  |  |  |  |  |  | 500,000 | 500,000 | 500,000 | 500,000 | 500,000 | 500,000
Stock options granted to purchase common stock, issued |  |  |  |  |  |  |  |  |  |  | 500,000 | 500,000 |  |  |  |
Five Non Officer Directors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of fully vested option exercisable | 100,000 |  | 100,000 |  |  |  |  |  |  |  | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000
BasvanderBaan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options description |  | the Board of Directors appointed Bas van der Baan to the Board of Directors. In connection with his appointment to the Board of Directors, and in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, Mr. Baan was granted options exercisable for a period of five years to purchase 250,000 shares of the Company’s common stock at an exercise price of $0.74 per share (the closing market price on the grant date), vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $158,525 ($0.6341 per share), of which $79,263 was attributable to the stock options fully-vested on June 17, 2022 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from June 17, 2022 through June 30, 2024. During the three months and six months ended June 30, 2022, the Company recorded a charge to general and administrative costs in the consolidated statement of operations of $80,647 with respect to these stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock option vested exercisable term |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  | $ 0.74 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  | $ 158,525 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  | $ 0.6341 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | $ 80,647 |  | $ 80,647 |
Number of fully vested option exercisable |  | 250,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options granted to purchase common stock, issued |  | 79,263 |  |  |  |  |  |  |  |  |  |  |  |  |  |
DrWinson SzeChunHo [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of fully vested option issued |  |  |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |
DrYunYen [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of fully vested option issued |  |  |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |
DrStephenForman [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of fully vested option issued |  |  |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |
Philip Palmedo [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of fully vested option issued |  |  |  |  |  | 50,000 |  |  |  |  |  |  |  |  |  |
Eric J. Forman [Member] | Employment Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options description |  |  |  |  |  |  |  |  | On July 15, 2020, as amended on August 12, 2020, in connection with the employment agreement entered into with Eric J. Forman, Mr. Forman was granted options for 58,333 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing market price of the Company’s common stock on the grant date. The options vested as to 25% on August 12, 2020 and August 12, 2021, and will vest 25% on each of the second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($6.8718 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from August 12, 2020 through August 12, 2023. During the three months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $24,985 and $24,985, respectively, with respect to these stock options. During the six months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $49,695 and $49,695, respectively, with respect to these stock options |  |  |  |  |  |  |
Stock options granted to purchase common stock, issued |  |  |  |  |  |  |  |  | 58,333 |  |  |  |  |  |  |
Stock option vested exercisable term |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  |  |  |  | $ 7.14 |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  |  |  |  | $ 400,855 |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  |  |  |  | $ 6.8718 |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  |  |  | $ 100,214 |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | 24,985 | $ 24,985 | 49,695 | $ 49,695
Dr. James Miser [Member] | Employment Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options description |  |  |  |  |  |  |  | Dr. James S. Miser, M.D., Dr. Miser was granted options for 83,334 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing market price of the Company’s common stock on the effective date of the employment agreement. The options vested as to 25% on August 1, 2020 and August 1, 2021, and will vest 25% on each of the second and third anniversaries of the effective date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $572,650 ($6.8718 per share), of which $143,163 was attributable to the stock options fully-vested on August 1, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from August 1, 2020 through August 1, 2023. During the three months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $35,693 and $35,693, respectively, with respect to these stock options. During the six months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $70,993 and $70,993, respectively, with respect to these stock options |  |  |  |  |  |  |  |
Stock options granted to purchase common stock, issued |  |  |  |  |  |  |  | 83,334 |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  |  |  | $ 7.14 |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  |  |  | $ 572,650 |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  |  |  | $ 6.8718 |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  |  |  |  | $ 143,163 |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | 35,693 | 35,693 | 70,993 | 70,993
Robert N. Weingarten [Member] | Employment Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options description |  |  |  |  |  |  | On August 12, 2020, in connection with the employment agreement entered into with Robert N. Weingarten, Mr. Weingarten was granted options for 58,333 shares of the Company’s common stock. The options can be exercised on a cashless basis. The options have a term of five years and an exercise price of $7.14 per share, which was equal to the closing market price of the Company’s common stock on the grant date. The options vested as to 25% on August 12, 2020 and August 12, 2021, and will vest 25% on each of the second and third anniversaries of the grant date. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $400,855 ($6.8718 per share), of which $100,214 was attributable to the stock options fully-vested on August 12, 2020 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from August 12, 2020 through August 12, 2023. During the three months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $24,985 and $24,985, respectively, with respect to these stock options. During the six months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $49,695 and $49,695, respectively, with respect to these stock options |  |  |  |  |  |  |  |  |
Stock options granted to purchase common stock, issued |  |  |  |  |  |  | 58,333 |  |  |  |  |  |  |  |  |
Stock option vested exercisable term |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  |  |  | $ 7.14 |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  |  |  | $ 400,855 |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  |  |  | $ 6.8718 |  |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  |  |  | $ 100,214 |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | 24,985 | 24,985 | 49,695 | 49,695
DrWinson SzeChunHo [Member] | Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options description |  |  |  |  | Winson Sze Chun Ho resigned from the Company’s Board of Directors to focus on clinical and pre-clinical cancer research in academic medicine. Concurrent with his resignation, the Board of Directors appointed Gil Schwartzberg to fill the vacancy created by Dr. Ho’s resignation. In connection with his appointment to the Board of Directors, and in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, Mr. Schwartzberg was granted options exercisable for a period of five years to purchase 250,000 shares of the Company’s common stock at an exercise price of $3.20 per share (the closing market price on the grant date), vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $753,611 ($3.0144 per share), of which $376,800 was attributable to the stock options fully-vested on April 9, 2021 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from April 9, 2021 through June 30, 2023. During the three months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $42,228 and $414,851, respectively, with respect to these stock options. During the six months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $83,992 and $414,851, respectively, with respect to these stock options |  |  |  |  |  |  |  |  |  |  |
Stock option vested exercisable term |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  |  | $ 3.20 |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  |  | $ 753,611 |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  |  | $ 3.0144 |  |  |  |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  |  | $ 376,800 |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | 42,228 | 414,851 | 83,992 | 414,851
Number of fully vested option exercisable |  |  |  |  | 250,000 |  |  |  |  |  |  |  |  |  |  |
Ms.Regina Brown [Member] | Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options description |  |  |  | the Board of Directors appointed Regina Brown to the Board of Directors. In connection with her appointment to the Board of Directors, and in accordance with the Company’s cash and equity compensation package for members of the Board of Directors, Ms. Brown was granted options exercisable for a period of five years to purchase 250,000 shares of the Company’s common stock at an exercise price of $2.80 per share (the closing market price on the grant date), vesting 50% on the grant date and the remainder vesting 12.5% on the last day of each subsequent calendar quarter-end until fully vested. The fair value of these stock options, as calculated pursuant to the Black-Scholes option-pricing model, was determined to be $658,363 ($2.6335 per share), of which $329,188 was attributable to the stock options fully-vested on May 11, 2021 and was therefore charged to operations on that date. The remaining unvested portion of the fair value of the stock options is being charged to operations ratably from May 11, 2021 through June 30, 2023. During the three months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $38,405 and $350,290, respectively, with respect to these stock options. During the six months ended June 30, 2022 and 2021, the Company recorded charges to general and administrative costs in the consolidated statement of operations of $76,388 and $350,290, respectively, with respect to these stock options |  |  |  |  |  |  |  |  |  |  |  |
Stock option vested exercisable term |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |
Stock options are exercisable price per share |  |  |  | $ 2.80 |  |  |  |  |  |  |  |  |  |  |  |
Fair value of stock options |  |  |  | $ 658,363 |  |  |  |  |  |  |  |  |  |  |  |
Stock price per share |  |  |  | $ 2.6335 |  |  |  |  |  |  |  |  |  |  |  |
Stock options fully vested amount, fair value |  |  |  | $ 329,188 |  |  |  |  |  |  |  |  |  |  |  |
Stock based compensation |  |  |  |  |  |  |  |  |  |  |  |  | $ 38,405 | $ 350,290 | $ 76,388 | $ 350,290
Number of fully vested option exercisable |  |  |  | 250,000 |  |  |  |  |  |  |  |  |  |  |  |
2020 Stock Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued | 2,100,000 |  |  |  |  |  |  |  |  |  | 2,100,000 |  | 2,100,000 |  | 2,100,000 |
Shares outstanding | 2,100,000 |  |  |  |  |  |  |  |  |  | 2,100,000 |  | 2,100,000 |  | 2,100,000 |
Shares were available for issuance | 233,333 |  |  |  |  |  |  |  |  |  | 233,333 |  | 233,333 |  | 233,333 |
2020 Stock Incentive Plan [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of restricted stock issued |  |  |  |  |  |  |  |  |  | 2,333,333 |  |  |  |  |  |

X
- Definition Fair value of stock options. + References No definition available. + Details
Name: | LIXT_FairValueOfStockOptions
Namespace Prefix: | LIXT_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The compensation expense recognized during the period pertaining to the deferred compensation arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -SubTopic 10 -Section 30 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363 + Details
Name: | us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of noncash expense for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Gross number of share options (or share units) granted during the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Price of a single share of a number of saleable stocks of a company. + References No definition available. + Details
Name: | us-gaap_SharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of non-vested options outstanding. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of options vested. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644 + Details
Name: | us-gaap_SharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued which are neither cancelled nor held in the treasury. + References No definition available. + Details
Name: | us-gaap_SharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_DirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=LIXT_NonOfficerDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=LIXT_FiveNonOfficerDirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=LIXT_BasvanderBaanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=LIXT_DrWinsonSzeChunHoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=LIXT_DrYunYenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=LIXT_DrStephenFormanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=LIXT_PhilipPalmedoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_EricJFormanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=LIXT_EmploymentAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_DrJamesMiserMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_RobertNWeingartenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_DrWinsonSzeChunHoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_MsReginaBrownMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=LIXT_TwoThousandTwentyStockIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |